Overexpression of VEGF-C correlates with a poor prognosis in esophageal cancer patients

Cancer Biomarkers

Volumn 17, Issue 2, 2016, Pages 165-170

  Xia, Haifeng ^a   Shen, Ji ^b   Chen, Shaomu ^a   Huang, Haitao ^a   Xu, Yaozeng ^b   Ma, Haitao ^a  

^a SOOCHOW UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Esophageal cancer; Meta analysis; Prognosis; VEGF C

Indexed keywords

VASCULOTROPIN C; TUMOR MARKER;

ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; META ANALYSIS (TOPIC); OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; CANCER GRADING; ESOPHAGUS TUMOR; GENE EXPRESSION; GENETICS; META ANALYSIS; MORTALITY; ODDS RATIO; PATHOLOGY; PROGNOSIS; PUBLISHING;

BIOMARKERS, TUMOR; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION; HUMANS; NEOPLASM GRADING; NEOPLASM STAGING; ODDS RATIO; PROGNOSIS; PUBLICATION BIAS; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84981717364     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-160627     Document Type: Article

References (36)

1. Jemal A., et al., Global cancer statistics. CA Cancer J Clin, 2011; 61(2): 69-90.
2. Koshy M., et al., Multiple management modalities in esophageal cancer: Combined modality management approaches. Oncologist, 2004; 9(2): 147-159.
3. Moskal T. L., et al., Serum levels of transforming growth factor alpha in gastrointestinal cancer patients. Cancer Epidemiology Biomarkers & Prevention, 1995; 4(2): 127-131.
4. Kimura Y., et al., Vascular endothelial growth factor C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma. Oncol Rep, 2003; 10(6): 1747-1751.
5. Karpanen T., et al., Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res, 2001; 61(5): 1786-1790.
6. Padera T. P., et al., Lymphatic metastasis in the absence of functional intratumor lymphatics. Science, 2002; 296(5574): 1883-1886.
7. Su JL., et al., The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell, 2006; 9(3): 209-223.
8. Jiang H., et al., VEGF-C in non-small cell lung cancer: metaanalysis. Clin Chim Acta, 2014; 427: 94-99.
9. Yang L. P., et al., Expression of vascular endothelial growth factor C correlates with lymphatic vessel density and prognosis in human gastroesophageal junction carcinoma. Onkologie, 2012; 35(3): 88-93.
10. Wang T. B., et al., Serum vascular endothelial growth factor-C and lymphoangiogenesis are associated with the lymph node metastasis and prognosis of patients with colorectal cancer. ANZ J Surg, 2011; 81(10): 694-699.
11. Acs G., et al., The extent of retraction clefts correlates with lymphatic vessel density and VEGF-C expression and predicts nodal metastasis and poor prognosis in early-stage breast carcinoma. Mod Pathol, 2012; 25(2): 163-177.
12. Pengchong H., et al., Expression of IGF-1R, VEGF-C and D2-40 and their correlation with lymph node metastasis in endometrial adenocarcinoma. Eur J Gynaecol Oncol, 2011; 32(6): 660-664.
13. Ma D. M., et al., Expression of vascular endothelial growth factor C correlates with a poor prognosis based on analysis of prognostic factors in patients with cervical carcinomas. J Obstet Gynaecol Res, 2011; 37(11): 1519-1524.
14. Xie Y. L., et al., Nuclear survivin expression is associated with a poor prognosis in Caucasian non-small cell lung cancer patients. Clin Chim Acta, 2012; 414: 41-43.
15. Parmar M. K., et al., Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med, 1998; 17(24): 2815-2834.
16. Zhan P., et al., Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: A systematic review with meta-analysis. J Thorac Oncol, 2009; 4(9): 1094-1103.
17. Higgins J. P., et al., Measuring inconsistency in meta-analyses. BMJ, 2003; 327(7414): 557-560.
18. Egger M., et al., Bias in meta-analysis detected by a simple, graphical test. BMJ, 1997; 315(7109): 629-634.
19. Zhang L.Q., et al. Prognostic Value of Survivin in Patients with Non-small Cell Lung Carcinoma: A Systematic Review with Meta-analysis. PLoS One, 2012; 7(3): E34100
20. Katsuta M., et al., Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer. Exp Mol Pathol, 2005; 78(2): 123-130.
21. Matsumoto S., et al., Prognostic significance of plateletderived growth factor-BB expression in human esophageal squamous cell carcinomas. Anticancer Res, 2007; 27(4B): 2409-2414.
22. Kimura H., et al., Preoperative serum vascular endothelial growth factor-C (VEGF-C) levels predict recurrence in patients with esophageal cancer. Anticancer Res, 2008; 28(1A): 165-169.
23. Inoue A., et al., Intratumoral lymphangiogenesis of esophageal squamous cell carcinoma and relationship with regulatory factors and prognosis. Pathol Int, 2008; 58(10): 611-619.
24. Okazawa T., et al., Expression of vascular endothelial growth factor C is a prognostic indicator in esophageal cancer. Hepatogastroenterology, 2008; 55(86-87): 1503-1508.
25. Liu P., et al., Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas. Jpn J Clin Oncol, 2009; 39(10): 644-650.
26. Kozlowski M., et al., Serum vascular endothelial growth factors C and D in patients with oesophageal cancer. Eur J Cardiothorac Surg, 2010; 38(3): 260-267.
27. Tanaka T., et al., Vascular endothelial growth factor C (VEGFC) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis. J Exp Clin Cancer Res, 2010; 29: 83.
28. KozlowskiM., et al., Vascular endothelial growth factor C and D expression correlates with lymph node metastasis and poor prognosis in patients with resected esophageal cancer. Neoplasma, 2011; 58(4): 311-319.
29. Sun Z. G., et al., Mucin 1 and vascular endothelial growth factor C expression correlates with lymph node metastatic recurrence in patients with N0 esophageal cancer after Ivor-Lewis esophagectomy. World J Surg, 2011; 35(1): 70-77.
30. Wang X., VEGF-C: an indicator of lymph node metastasis for patients that underwent esophagectomy. Hepatogastroenterology, 2012; 59(119): 2027-2031.
31. Juchniewicz A., et al., Prognostic value of vascular endothelial growth factor-C and podoplanin mRNA expression in esophageal cancer. Oncol Lett, 2015; 10(6): 3668-3674.
32. Wang L., et al., Cyclin e expression and prognosis in breast cancer patients: A meta-analysis of published studies. Cancer Invest, 2006; 24(6): 581-587.
33. Nakamura H., et al., Survival impact of epidermal growth factor receptor overexpression in patients with non-small cell lung cancer: A meta-analysis. Thorax, 2006; 61(2): 140-145.
34. Meert A. P., et al., The role of EGF-R expression on patient survival in lung cancer: A systematic review with metaanalysis. Eur Respir J, 2002; 20(4): 975-981.
35. Huang Y. J., et al., The prognostic value of surviving expression in patients with colorectal carcinoma: a meta-analysis. Jpn J Clin Oncol, 2013; 43(10): 988-995.
36. He J., et al., Prognostic role of microRNA-155 in various carcinomas: results from a meta-analysis. Dis Markers, 2013; 34(6): 379-386.